Company profile PHIO

Phio Pharmaceuticals Corp
phio pharmaceuticals corp., a biotechnology company, develops immuno-oncology therapeutics in the united states. it offers intasyl therapeutic platform focuses on silencing tumor-induced suppression of the immune system. the company develops ph-762 which targets the checkpoint protein pd-1 on immune cells for used in adoptive cell transfer (act); ph-804 that targets the suppres...sive immune receptor tigit, which is a checkpoint protein present on t cells and natural killer cells for used in act; and ph-790 which targets pd-l1 protein that keeps immune cells from attacking nonharmful cells in the body. it has collaborations with the gustave roussy and medigene ag, as well as with helmholtz zentrum mã¼nchen. the company was formerly known as rxi pharmaceuticals corporation and changed its name to phio pharmaceuticals corp. in november 2018. phio pharmaceuticals corp. was incorporated in 2011 and is headquartered in marlborough, massachusetts. Show More
Quarter analysis & expected interest

There is not enough data for Immuno-oncology therapeutics to provide analysis

Correlation between past revenue and Immuno-oncology therapeutics search interest

There is not enough data for Immuno-oncology therapeutics to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Immuno-oncology therapeutics to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for PH-762 to provide analysis

Correlation between past revenue and PH-762 search interest

There is not enough data for PH-762 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for PH-762 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for INTASYL compound to provide analysis

Correlation between past revenue and INTASYL compound search interest

There is not enough data for INTASYL compound to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for INTASYL compound to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for PH-894 to provide analysis

Correlation between past revenue and PH-894 search interest

There is not enough data for PH-894 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for PH-894 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for BRD4 protein to provide analysis

Correlation between past revenue and BRD4 protein search interest

There is not enough data for BRD4 protein to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for BRD4 protein to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for PH-804 to provide analysis

Correlation between past revenue and PH-804 search interest

There is not enough data for PH-804 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for PH-804 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for TIGIT protein to provide analysis

Correlation between past revenue and TIGIT protein search interest

There is not enough data for TIGIT protein to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for TIGIT protein to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Phio Pharmaceuticals Corp. to provide analysis

Correlation between past revenue and Phio Pharmaceuticals Corp. search interest

There is not enough data for Phio Pharmaceuticals Corp. to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Phio Pharmaceuticals Corp. to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:40:23.

After 39 days of this quarter the interest is at 36.0. Based on that we can calculate that during remaining 52 days it will total up to 84.0.
RXi Pharmaceuticals expected interest is significantly lower compared to previous quarter (-48.1%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201974
149
101.4% QoQ
0
-100.0% QoQ
98
inf% QoQ
2020 101
36.5% YoY 3.1% QoQ
15
-89.9% YoY -85.1% QoQ
20
inf% YoY 33.3% QoQ
196
100.0% YoY 880.0% QoQ
2021 56
-44.6% YoY -71.4% QoQ
73
386.7% YoY 30.4% QoQ
64
220.0% YoY -12.3% QoQ
242
23.5% YoY 278.1% QoQ
2022 23
-58.9% YoY -90.5% QoQ
128
75.3% YoY 456.5% QoQ
89
39.1% YoY -30.5% QoQ
45
-81.4% YoY -49.4% QoQ
2023 89
287.0% YoY 97.8% QoQ
111
-13.3% YoY 24.7% QoQ
134
50.6% YoY 20.7% QoQ
162
260.0% YoY 20.9% QoQ
2024 36
-59.6% YoY -77.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and RXi Pharmaceuticals search interestLast update: February 09 2024 18:40:22.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:40:25.

The average 5 years interest of RXi Pharmaceuticals was 7.3 per week.
The last year interest of RXi Pharmaceuticals compared to the last 5 years has changed by 16.71%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 28.7%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:40:31.

After 39 days of this quarter the interest is at 394.0. Based on that we can calculate that during remaining 52 days it will total up to 919.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019501
753
50.3% QoQ
756
0.4% QoQ
738
-2.4% QoQ
2020 879
75.4% YoY 19.1% QoQ
963
27.9% YoY 9.6% QoQ
767
1.5% YoY -20.4% QoQ
812
10.0% YoY 5.9% QoQ
2021 857
-2.5% YoY 5.5% QoQ
807
-16.2% YoY -5.8% QoQ
842
9.8% YoY 4.3% QoQ
853
5.0% YoY 1.3% QoQ
2022 977
14.0% YoY 14.5% QoQ
886
9.8% YoY -9.3% QoQ
894
6.2% YoY 0.9% QoQ
847
-0.7% YoY -5.3% QoQ
2023 929
-4.9% YoY 9.7% QoQ
893
0.8% YoY -3.9% QoQ
929
3.9% YoY 4.0% QoQ
1000
18.1% YoY 7.6% QoQ
2024 394
-57.6% YoY -60.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Healthcare search interestLast update: February 09 2024 18:40:31.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:40:32.

The average 5 years interest of Healthcare was 66.2 per week.
The last year interest of Healthcare compared to the last 5 years has changed by 7.78%.
The interest for Healthcare is relatively stable in the last 5 years.
The last year interest is quite higher compared to 5 years ago. It has increased by 20.93%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:40:38.

After 39 days of this quarter the interest is at 345.0. Based on that we can calculate that during remaining 52 days it will total up to 805.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019558
719
28.9% QoQ
632
-12.1% QoQ
679
7.4% QoQ
2020 886
58.8% YoY 30.5% QoQ
723
0.6% YoY -18.4% QoQ
711
12.5% YoY -1.7% QoQ
585
-13.8% YoY -17.7% QoQ
2021 760
-14.2% YoY 29.9% QoQ
629
-13.0% YoY -17.2% QoQ
561
-21.1% YoY -10.8% QoQ
564
-3.6% YoY 0.5% QoQ
2022 815
7.2% YoY 44.5% QoQ
813
29.3% YoY -0.2% QoQ
677
20.7% YoY -16.7% QoQ
697
23.6% YoY 3.0% QoQ
2023 893
9.6% YoY 28.1% QoQ
743
-8.6% YoY -16.8% QoQ
644
-4.9% YoY -13.3% QoQ
752
7.9% YoY 16.8% QoQ
2024 345
-61.4% YoY -54.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Biotechnology search interestLast update: February 09 2024 18:40:36.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:40:39.

The average 5 years interest of Biotechnology was 55.12 per week.
The last year interest of Biotechnology compared to the last 5 years has changed by 3.41%.
The interest for Biotechnology is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by 1.55%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for PHIO
Earnings date: 2024-03-20 After close
Company name: Phio Pharmaceuticals Corp
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-03-10T11:59:39Z

GlobeNewswire
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT

2026-02-10T17:55:09Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on Phio Pharma, Maintains $14 Price Target

2025-09-15T16:02:03-04:00

SEC
4/A Form - [Amend] Statement of changes in beneficial ownership of securities - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

2025-09-15T16:01:27-04:00

SEC
8-K Form - Current report, items 5.02 and 5.07 - Phio Pharmaceuticals Corp. (0001533040) (Filer)

2025-09-15T08:30:15-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

2025-09-15T08:29:58-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

2025-09-15T08:29:41-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

2025-09-15T08:29:12-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

2025-09-15T08:28:50-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

2025-09-15T08:28:35-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

2025-09-15T08:28:05-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

2025-09-11T09:58:15-04:00

SEC
S-8 Form - Securities to be offered to employees in employee benefit plans - Phio Pharmaceuticals Corp. (0001533040) (Filer)

2025-09-03T08:08:28-04:00

SEC
8-K Form - Current report, items 8.01 and 9.01 - Phio Pharmaceuticals Corp. (0001533040) (Filer)

2025-08-28T16:01:04-04:00

SEC
DEFA14A Form - Additional definitive proxy soliciting materials and Rule 14(a)(12) material - Phio Pharmaceuticals Corp. (0001533040) (Filer)

2025-08-27T17:04:25-04:00

SEC
424B3 Form - Prospectus [Rule 424(b)(3)] - Phio Pharmaceuticals Corp. (0001533040) (Filer)